Consumer & Travel Stock News
Sunday, September 06, 2026
Nike Set for S&P 100 Removal Following 80% Share Price Collapse
Nike is scheduled for removal from the S&P 100 index at the conclusion of this month, marking the end of the footwear giant's nearly 18-year tenure in the...
Optimi Health Corp. Common Shares Q2 2026 Earnings Preview: What Analysts Expect on September 07, 2026
Optimi Health is expected to report a Q2 2026 loss of $0.26 per share on estimated revenue of $0.13 million, with its current stock price of $4.78 trading well...
Grifols SA Q2 2026 Earnings Preview: What Analysts Expect on September 07, 2026
Wall Street analysts expect Grifols SA to report Q2 2026 revenue of $2.23 billion and earnings of $0.27 per share, while the stock currently trades at $7.80...
🔴 Egyptian Media Production City is trading 3.2% down with no clear catalyst identified
Egyptian Media Production City is trading 3.2% down at $42.60 after no clearly documented company-specific catalyst was identified for the September 4, 2026...
US Government Probes Alleged Link Between COVID-19 Vaccines and Military Deaths
GSK signs $1.3 billion HUTCHMED deal, targeting KRAS-driven cancers
Alibaba edges higher, following Michael Burry super fat pitch call
Toyota Pivots to Hydrogen Trucks, Targeting Rising Supply Chain Costs
Other News
Funko CFO cuts stake by 50%, following recent earnings beat
Burlington Stores Moves HQ to Philadelphia in $370 Million Expansion
BlackRock Discloses New 4.21% Stake in Neumora Therapeutics
Atlas Venture Buys $113.9M Kailera Stake, Its Fourth-Largest Holding
easyJet faces two-day French pilot strike, citing scheduling instability
Cipla partners with Qilu for US Keytruda biosimilar, targeting oncology growth
Royalty Pharma loses pelacarsen upside, as Novartis Phase 3 trial fails
AstraZeneca Wins FDA Approval for Etcamah, Cutting Cancer Progression Risk 56%
Hongkong Land Eyes $1B Tokyo Entry, Seeking Higher Returns
Ionis' Partnered Drug Pelacarsen Fails to Meet Primary Endpoint in Phase 3 Study
Netflix Hikes UK Prices for Second Time, Ad-Tier Jumps 33%
Wells Fargo Raises Merck Target to $170, Citing $5B Heart Drug Potential
BMW Recalls 189,130 Vehicles, Citing Starter Motor Fire Risk
Airbnb faces EU-wide rental limits, citing local housing stress
Jasper Therapeutics Proposes Reverse Split, Aiming to Save Nasdaq Listing
Warner Music Group Amends Employment Agreement for Acting CFO Louis Dickler
AIM ImmunoTech Satisfies Promissory Note Through a $1.22M Debt-for-Equity Exchange
Intellia Therapeutics Secures up to $400 Million Non-Dilutive Debt Facility with OrbiMed
Ionis Pharmaceuticals Receives FDA Approval for ZANVASTRO™ for Alexander Disease
Intellia Therapeutics Lands $400 Million to Fuel CRISPR Drug Launch
Novo Nordisk Announces Strategic Collaboration to Build Quantum Chip Facility
BlackRock buys 9.2% stake in Arcturus, targeting mRNA biotech growth
GT Biopharma's 1-for-25 Reverse Split: A Lifeline to Stay Listed or a Warning Sign for Investors?
Veraxa Biotech Swaps CFOs and Stock Jumps 23% in a Week — Can a New Finance Chief Revive a Sub-$2 Stock?
Chevron to Invest $7B in Venezuelan Oil Expansion
Bank of Canada Holds Rates, Warns on U.S. Trade War
G20 Nations Isolate China Over Trade Policies
Japanese Bond Yields Hit 30-Year High